Effects of a single infusion of pamidronate prior to liver transplantation: A bone histomorphometric study

Transplant International

Volumn 15, Issue 6, 2002, Pages 290-295

  Vedi, Shobna ^a   Ninkovic, Mary ^a   Garrahan, Nigel J ^b   Alexander, Graeme J M ^a   Compston, Juliet E ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Bone turnover; Liver transplantation; Osteoporosis; Pamidronate

Indexed keywords

ALEMTUZUMAB; ALFACALCIDOL; CALCIUM; CYCLOSPORIN; ETIDRONIC ACID; METHYLPREDNISOLONE; PAMIDRONIC ACID; PREDNISOLONE;

ADULT; ARTICLE; BONE BIOPSY; BONE EROSION; BONE REMODELING; BONE TURNOVER; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; ILIAC CREST; IMAGE ANALYSIS; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; MALE; MORPHOMETRICS; OSTEOLYSIS; OSTEOPOROSIS; PREOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ADULT; BONE REMODELING; BONE RESORPTION; DIPHOSPHONATES; FEMALE; HUMAN; LIVER TRANSPLANTATION; MALE; MIDDLE AGE; OSTEOPOROSIS; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; SUPPORT, NON-U.S. GOV'T;

EID: 0036937873     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2002.tb00167.x     Document Type: Article

References (35)

1. Haagsma EB, Thijn CJP, Post JG, Slooff MJH, Gips CH (1988) Bone disease after orthotopic liver transplantation. J Hepatol 6:94-100
2. McDonald JA, Dunstan CR, Dilworth P, Sherbon K, Ross Sheil AG, Evans RA, McCaughan GW (1991) Bone loss after liver transplantation. Hepatology 14:613-619
3. Porayko MK, Wiesner RH, Hay JE, Krom RAF, Dickson ER, Beaver S, Schwerman L (1991) Bone disease in liver transplant recipients: incidence, timing and risk factors. Transplant Proc 23:1462-1465
4. Arnold JC, Hauser D, Ziegler R, Kommerelle B, Otto G, Theilmann L, Wüster C (1992) Bone disease after liver transplantation. Transplant Proc 24:2709-2710
5. Meys E, Fontagnes E, Fourcade N, Thomasson A, Pouyet M, Delmas PD (1994) Bone disease after orthotopic liver transplantation. Am J Med 97:445-450
6. Navasa M, Monegal A, Guanabens N, Peris P, Rimola A, Munoz-Gomez J, Visa J, Rodes J (1994) Bone fractures in liver transplant patients. Br J Rheumatol 33:52-55
7. Eastell R, Dickson ER, Hodgson SF, Wiesner RH, Porayko MK, Wahner HW, Cedel SL, Riggs BL, Krom RAF (1991) Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis. Hepatology 14:296-300
8. Abdelhadi M, Eriksson SAV, Eriksson SL, Ericzon B-G, Nordenström J (1995) Bone mineral status in end-stage liver disease and the effect of liver transplantation. Scand J Gastroenterol 30:1210-1215
9. Ninkovic M, Skingle SJ. Bearcroft PWP, Bishop N, Alexander GJM, Compston JE (2000) Incidence of vertebral fractures in the first three months after orthotopic liver transplantation. Eur J Gastroenterol Hepatol 12:931-935
10. Epstein S (1996) Post-transplantation bone disease: the impact of immunosuppressive agents on the skeleton. J Bone Miner Res 11:1-7
11. Rodino MA, Shane E (1998) Osteoporosis after organ transplantation. Am J Med 104:459-469
12. Vedi S, Greer S, Skingle SJ, Garrahan NJ, Ninkovic M, Alexander GM, Compston JE (1999) Mechanism of bone loss after liver transplantation: a histomorphometric analysis. J Bone Miner Res 14:281-287
13. Ninkovic M, Love SA, Thom B, Skingle S, Wright JS, Alexander GJM, Compston JE (2000) The effects of a single pamidronate infusion prior to liver transplantation on bone loss: a randomised controlled trial. Osteoporos Int 11:[Suppl 2]S113
14. Frost HM (1969) Tetracycline-based histological analysis of bone remodeling. Calcif Tissue Int 3:211-237
15. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR (1987) Bone histomorphometry: standardization of nomenclature, symbols and units. J Bone Miner Res 2:595-610
16. Garrahan NJ, Croucher PI, Compston JE (1990) A computerised technique for the quantitative assessment of resorption cavities in trabecular bone. Bone 11:241-246
17. Garrahan NJ, Mellish RWE, Compston JE (1986) A new method for the analysis of two-dimensional trabecular bone structure in human iliac crest biopsies. J Microsc 142:341-349
18. Hahn M, Vogel M, Pompesius-Kempa M, Delling G (1992) Trabecular bone pattern factor - a new parameter for simple quantification of bone microarchitecture. Bone 13:327-330
19. Vesterby A, Gundersen HJG, Melsen F (1989) Star volume of marrow space and trabeculae of the first lumbar vertebra: sampling efficiency and biological variation. Bone 10:7-13
20. Croucher PI, Garrahan NJ, Compston JE (1996) Assessment of cancellous bone structure: comparison of strut analysis, trabecular bone pattern factor and marrow space star volume. J Bone Miner Res 11:955-961
21. Russell RGG, Croucher PI, Rogers MJ (1999) Bisphosphonates: pharmacology, mechanisms of action and clinical use. Osteoporos Int 2 [Suppl] S66-S80
22. Hughes DE, Wright KR, Uy HL, Sasaki A, Yoneda T, Roodman GD, Mundy GR, Boyce BF (1995) Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res 10:1478-1487
23. Plotkin LI, Weinstein RS, Parfitt MA, Roberson PK, Manolagas SC, Bellido T (1999) Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest 104:1363-1374
24. Chavassieux PM, Arlot ME, Reda C, Wei L, Yates AJ, Meunier PJ (1997) Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis. J Clin Invest 100:1475-1480
25. Chavassieux PM, Arlot ME, Roux JP, Portero N, Daifotis A, Yates AJ, Hamdy NAT, Malice M-P, Freedholm D, Meunier PJ (2000) Effects of alendronate on bone quality and remodeling in glucocorticoid-induced osteoporosis: a histomorphometric analysis of transiliac biopsies. J Bone Miner Res 15:754-762
26. Bravenboer N, Papapoulos SE, Holzmann P, Hamdy NAT, Netelenbos JC, Lips P (1999) Bone histomorphometric evaluation of pamidronate treatment in clinically manifest osteoporosis. Osteoporos Int 9:489-493
27. Adamson BB, Gallacher SJ, Byars J, Ralston SH, Boyle IT, Boyce BF (1993) Mineralisation defects with pamidronate therapy for Paget's disease. Lancet 342:1459-1469
28. Boyce BF, Smith L, Fogelman I, Johnston E, Ralston S, Boyle IT (1984) Focal osteomalacia due to low-dose diphosphonate therapy. Lancet i:821-824
29. Riemens SC, Oostdijk A, van Doormaal JJ, Thijn CJP, Drent G, Piers DA, Groen EWJ, Meerman L, Slooff MJH, Haagsma EB (1996) Bone loss after liver transplantation is not prevented by cyclical etidronate, calcium and alphacalcidol. Osteoporos Int 6:213-218
30. Valero MA, Loinaz C, Larrodera L, Leon M, Moreno E, Hawkins F (1995) Calcitonin and bisphosphonates treatment in bone loss after liver transplantation. Calcif Tissue Int 57:15-19
31. Neuhaus R, Kubo A, Lohmann R, Rayes N, Hierholzer J, Neuhaus P (1999) Calcitriol in prevention and therapy of osteoporosis after liver transplantation. Transplant Proc 31:472-473
32. Reeves HL, Francis RM, Manas DM, Hudson M, Day CP (1998) Intravenous bisphosphonate prevents symptomatic osteoporotic vertebral collapse in patients after liver transplantation. Liver Transpl Surg 4:404-409
33. Bishop NJ, Ninkovic M, Alexander GJM, Holmes SD, Milligan T, Price C, Compston JE (1999) Changes in calcium homeostasis in patients undergoing liver transplantation: effects of a single infusion of pamidronate administered pre-operatively. Clin Sci 97:157-163
34. Stellon A, Webb A, Compston JE, Williams R (1987) Low bone turnover state in primary biliary cirrhosis. Hepatology 7:137-142
35. Stellon A, Webb A, Compston JE (1988) Bone histomorphometry and structure in corticosteroid treated chronic active hepatitis. Gut 29:378-384